Candid Health Revenue and Competitors
Estimated Revenue & Valuation
- Candid Health's estimated annual revenue is currently $57M per year.
- Candid Health's estimated revenue per employee is $382,711
- Candid Health's total funding is $100M.
Employee Data
- Candid Health has 149 Employees.
- Candid Health grew their employee count by 59% last year.
Candid Health's People
Name | Title | Email/Phone |
---|---|---|
1 | COO & Co-founder | Reveal Email/Phone |
2 | Chief Staff | Reveal Email/Phone |
3 | Head Product | Reveal Email/Phone |
4 | Head Sales | Reveal Email/Phone |
5 | Head Design | Reveal Email/Phone |
6 | Head Customer Operations | Reveal Email/Phone |
7 | Head Talent | Reveal Email/Phone |
8 | Product Manager | Reveal Email/Phone |
9 | Senior Product Manager | Reveal Email/Phone |
10 | Strategy & Operations | Reveal Email/Phone |
Candid Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $342.8M | 907 | -6% | N/A | N/A |
#2 | $7.3M | 34 | -3% | N/A | N/A |
#3 | $23.2M | 86 | -4% | N/A | N/A |
#4 | $63.9M | 215 | 32% | N/A | N/A |
#5 | $54.1M | 182 | 18% | N/A | N/A |
#6 | $23M | 85 | 2% | N/A | N/A |
#7 | $115.4M | 342 | 7% | N/A | N/A |
#8 | $133.3M | 395 | 3% | N/A | N/A |
#9 | $16.5M | 68 | -11% | N/A | N/A |
#10 | $801.9M | 2077 | 4% | $779M | N/A |
What Is Candid Health?
Candid Health is building a modern medical payments platform that enables healthcare providers to focus on delivering high-quality, affordable and accessible care, rather than spending half their time figuring out how to get paid by insurance.
keywords:N/A$100M
Total Funding
149
Number of Employees
$57M
Revenue (est)
59%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $43.2M | 149 | 3% | $27.4M |
#2 | $7.5M | 149 | 15% | $28.5M |
#3 | $34.4M | 149 | -4% | N/A |
#4 | $41.1M | 149 | 13% | N/A |
#5 | $16.4M | 149 | 21% | N/A |